Clinical Course and Outcome of COVID‐19 in Children With Biliary Atresia: A Retrospective Study DOI Creative Commons
Yifan Yang, Jingying Jiang,

Jin Zhou

et al.

Health Science Reports, Journal Year: 2025, Volume and Issue: 8(2)

Published: Feb. 1, 2025

To investigate the infection status and outcomes of biliary atresia (BA) patients during coronavirus disease 2019 (COVID-19) pandemic in Chinese population. This retrospective study involved Kasai-postoperative BA who had achieved jaundice-free SARS-CoV-2 outbreak from December 1, 2022 to February 28, 2023. Children without hepatobiliary diseases hospitalized same period were as control group. Data collected included nutritional status, comorbidities, epidemiologic characteristics, fever symptoms (duration, max), respiratory (cough, runny nose shortness breath), gastrointestinal (diarrhea vomiting). All cases infected with followed up for 3 months. A total 128 enrolled, ranged age 6 months 12 years old (median age: 1.8 years). 51 (39.8%) 49 (38.3%) classified confirmed suspected COVID-19 cases, respectively. Only two presented moderate symptoms, while rest developed asymptomatic or mild cases. Compared 115 groups, proportion symptomatic was slightly higher (78.1% vs. 67.8%) significant difference (p = 0.07). Similarly, no differences found fever, tract between groups. However, it is worth noting that 7 cholangitis infection, experienced pale stool elevated bilirubin levels. After hospitalization, six survival, but one child finally undergo liver transplantation due hepatic failure. The course similar those healthy vast majority made a good recovery COVID-19.

Language: Английский

Clinical Course and Outcome of COVID‐19 in Children With Biliary Atresia: A Retrospective Study DOI Creative Commons
Yifan Yang, Jingying Jiang,

Jin Zhou

et al.

Health Science Reports, Journal Year: 2025, Volume and Issue: 8(2)

Published: Feb. 1, 2025

To investigate the infection status and outcomes of biliary atresia (BA) patients during coronavirus disease 2019 (COVID-19) pandemic in Chinese population. This retrospective study involved Kasai-postoperative BA who had achieved jaundice-free SARS-CoV-2 outbreak from December 1, 2022 to February 28, 2023. Children without hepatobiliary diseases hospitalized same period were as control group. Data collected included nutritional status, comorbidities, epidemiologic characteristics, fever symptoms (duration, max), respiratory (cough, runny nose shortness breath), gastrointestinal (diarrhea vomiting). All cases infected with followed up for 3 months. A total 128 enrolled, ranged age 6 months 12 years old (median age: 1.8 years). 51 (39.8%) 49 (38.3%) classified confirmed suspected COVID-19 cases, respectively. Only two presented moderate symptoms, while rest developed asymptomatic or mild cases. Compared 115 groups, proportion symptomatic was slightly higher (78.1% vs. 67.8%) significant difference (p = 0.07). Similarly, no differences found fever, tract between groups. However, it is worth noting that 7 cholangitis infection, experienced pale stool elevated bilirubin levels. After hospitalization, six survival, but one child finally undergo liver transplantation due hepatic failure. The course similar those healthy vast majority made a good recovery COVID-19.

Language: Английский

Citations

0